{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Aurora kinase inhibitor", "Aurora kinases", "angiogenesis", "endothelial cells", "growth factors", "ovary cancer cell line"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36102296", "DateCompleted": {"Year": "2022", "Month": "09", "Day": "15"}, "DateRevised": {"Year": "2022", "Month": "10", "Day": "25"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "09", "Day": "14"}], "Language": ["eng"], "ELocationID": ["133", "10.3892/ijmm.2022.5189"], "Journal": {"ISSN": "1791-244X", "JournalIssue": {"Volume": "50", "Issue": "5", "PubDate": {"Year": "2022", "Month": "Nov"}}, "Title": "International journal of molecular medicine", "ISOAbbreviation": "Int J Mol Med"}, "ArticleTitle": "Dual roles of oxostephanine as an Aurora kinase inhibitor and angiogenesis suppressor.", "Abstract": {"AbstractText": ["The Aurora kinases, including Aurora A, B and\u00a0C, play critical roles in cell division. They have been found overexpressed in a number of types of cancer and may thus be potential targets in cancer therapy. Several Aurora kinase inhibitors have been identified and developed. Some of these have been used in clinical trials and have exhibited certain efficacy in cancer treatment. However, none of these has yet been applied clinically due to the poor outcomes. Oxostephanine is an aporphine alkaloid isolated from several plants of the genus Stephania. This compound has been reported to inhibit Aurora kinase activity in kinase assays and in cancer cells. The present study aimed to investigate the real\u2011time effects of oxostephanine extracted from <i>Stephania dielsiana</i> Y.C. Wu leaves on the growth of an ovarian cancer cell line (OVCAR\u20118, human ovarian carcinoma); these effects were compared to those of the well\u2011known Aurora kinase inhibitor, VX\u2011680. The effects of oxostephanine on stromal cells, as well as endothelial cells were also examined. The results demonstrated that oxostephanine was an Aurora kinase inhibitor through the prevention of histone H3 phosphorylation at serine 10, the mislocalization of Aurora B and the induction of aneuploidy. Moreover, this substance was selectively cytotoxic to human umbilical vein endothelial cells (hUVECs), whereas it was less cytotoxic to human fibroblasts and umbilical cord\u2011derived mesenchymal stem cells. In addition, this compound significantly attenuated the migration and tube formation ability of hUVECs. Taken together, the present study demonstrates that oxostephanine plays dual roles in inhibiting Aurora kinase activity and angiogenesis. Thus, it may have potential for use as a drug in cancer treatment."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Vietnam University of Traditional Medicine, Hanoi 10000, Vietnam."}], "LastName": "Tran", "ForeName": "Thu-Hien Thi", "Initials": "TT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology, Faculty of Biology, VNU University of Science, Vietnam National University, Hanoi 10000, Vietnam."}], "LastName": "Vu", "ForeName": "Le-Duy Ba", "Initials": "LB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Vietnam University of Traditional Medicine, Hanoi 10000, Vietnam."}], "LastName": "Nguyen", "ForeName": "Huy Quoc", "Initials": "HQ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology, Faculty of Biology, VNU University of Science, Vietnam National University, Hanoi 10000, Vietnam."}], "LastName": "Pham", "ForeName": "Hanh Bich", "Initials": "HB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology, Faculty of Biology, VNU University of Science, Vietnam National University, Hanoi 10000, Vietnam."}], "LastName": "Do", "ForeName": "Xuan-Phuong Thi", "Initials": "XT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Center of Applied Sciences,\u00a0Regenerative Medicine and Advance Technologies, Vinmec Healthcare System, Hanoi 10000, Vietnam."}], "LastName": "Than", "ForeName": "Uyen Thi Trang", "Initials": "UTT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "The Key Laboratory of Enzyme and Protein Technology, VNU University of Science, Vietnam National University, Hanoi 10000, Vietnam."}], "LastName": "Pham", "ForeName": "Thu-Huong Thi", "Initials": "TT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology, Faculty of Biology, VNU University of Science, Vietnam National University, Hanoi 10000, Vietnam."}], "LastName": "Do", "ForeName": "Linh Dieu", "Initials": "LD"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Faculty of Apothecary, National Institute of Medicinal Materials, Hanoi 10000, Vietnam."}], "LastName": "Le", "ForeName": "Kim-Van Thi", "Initials": "KT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Marine Biochemistry, Vietnam Academy of Science and Technology, Hanoi 10000, Vietnam."}], "LastName": "Nguyen", "ForeName": "Thao Phuong", "Initials": "TP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Cell Biology, Faculty of Biology, VNU University of Science, Vietnam National University, Hanoi 10000, Vietnam."}], "LastName": "Hoang", "ForeName": "My-Nhung Thi", "Initials": "MT"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Greece", "MedlineTA": "Int J Mol Med", "NlmUniqueID": "9810955", "ISSNLinking": "1107-3756"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antineoplastic Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Protein Kinase Inhibitors"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Protein Serine-Threonine Kinases"}], "MeshHeadingList": [{"QualifierName": ["pharmacology"], "DescriptorName": "Antineoplastic Agents"}, {"QualifierName": [], "DescriptorName": "Endothelial Cells"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Protein Kinase Inhibitors"}, {"QualifierName": [], "DescriptorName": "Protein Serine-Threonine Kinases"}], "CoiStatement": "The authors declare that they have no competing interests."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cowley DO, Rivera-P\u00e9rez JA, Schliekelman M, He YJ, Oliver TG, Lu L, O'Quinn R, Salmon ED, Magnuson T, Van Dyke T. Aurora-A kinase is essential for bipolar spindle formation and early development. Mol Cell Biol. 2009;29:1059\u20131071. doi: 10.1128/MCB.01062-08.", "ArticleIdList": ["10.1128/MCB.01062-08", "PMC2643803", "19075002"]}, {"Citation": "Barretta ML, Spano D, D'Ambrosio C, Cervigni RI, Scaloni A, Corda D, Colanzi A. Aurora-A recruitment and centrosomal maturation are regulated by a Golgi-activated pool of Src during G2. Nat Commun. 2016;7:11727. doi: 10.1038/ncomms11727.", "ArticleIdList": ["10.1038/ncomms11727", "PMC4895030", "27242098"]}, {"Citation": "Carmena M, Ruchaud S, Earnshaw WC. Making the Auroras glow: Regulation of Aurora A and B kinase function by inter-acting proteins. Curr Opin Cell Biol. 2009;21:796\u2013805. doi: 10.1016/j.ceb.2009.09.008.", "ArticleIdList": ["10.1016/j.ceb.2009.09.008", "PMC2806521", "19836940"]}, {"Citation": "Gurden MD, Anderhub SJ, Faisal A, Linardopoulos S. Aurora B prevents premature removal of spindle assembly checkpoint proteins from the kinetochore: A key role for Aurora B in mitosis. Oncotarget. 2016;9:19525\u201319542. doi: 10.18632/oncotarget.10657.", "ArticleIdList": ["10.18632/oncotarget.10657", "PMC5929406", "29731963"]}, {"Citation": "Shimada M, Goshima T, Matsuo H, Johmura Y, Haruta M, Murata K, Tanaka H, Ikawa M, Nakanishi K, Nakanishi M. Essential role of autoactivation circuitry on Aurora B-mediated H2AX-pS121 in mitosis. Nat Commun. 2016;7:12059. doi: 10.1038/ncomms12059.", "ArticleIdList": ["10.1038/ncomms12059", "PMC4941122", "27389782"]}, {"Citation": "Lan W, Zhang X, Kline-Smith SL, Rosasco SE, Barrett-Wilt GA, Shabanowitz J, Hunt DF, Walczak CE, Stukenberg PT. Aurora B phosphorylates centromeric MCAK and regulates its localization and microtubule depolymerization activity. Curr Biol. 2004;14:273\u2013286. doi: 10.1016/j.cub.2004.01.055.", "ArticleIdList": ["10.1016/j.cub.2004.01.055", "14972678"]}, {"Citation": "Mallm JP, Rippe K. Aurora kinase B regulates telomerase activity via a centromeric RNA in stem cells. Cell Rep. 2015;11:1667\u20131678. doi: 10.1016/j.celrep.2015.05.015.", "ArticleIdList": ["10.1016/j.celrep.2015.05.015", "26051938"]}, {"Citation": "Rosasco-Nitcher SE, Lan W, Khorasanizadeh S, Stukenberg PT. Centromeric Aurora-B activation requires TD-60, microtubules, and substrate priming phosphorylation. Science. 2008;319:469\u2013472. doi: 10.1126/science.1148980.", "ArticleIdList": ["10.1126/science.1148980", "18218899"]}, {"Citation": "Wang F, Dai J, Daum JR, Niedzialkowska E, Banerjee B, Stukenberg PT, Gorbsky GJ, Higgins JMG. Histone H3 Thr-3 phosphorylation by Haspin positions Aurora B at centromeres in mitosis. Science. 2010;330:231\u2013235. doi: 10.1126/science.1189435.", "ArticleIdList": ["10.1126/science.1189435", "PMC2967368", "20705812"]}, {"Citation": "Vader G, Medema RH, Lens SMA. The chromosomal passenger complex: Guiding Aurora-B through mitosis. J Cell Biol. 2006;173:833\u2013837. doi: 10.1083/jcb.200604032.", "ArticleIdList": ["10.1083/jcb.200604032", "PMC2063908", "16769825"]}, {"Citation": "Delacour-Larose M, Thi MNH, Dimitrov S, Molla A. Role of survivin phosphorylation by aurora B in mitosis. Cell cycle. 2007;6:1878\u20131885. doi: 10.4161/cc.6.15.4482.", "ArticleIdList": ["10.4161/cc.6.15.4482", "PMC3323923", "17671419"]}, {"Citation": "Otto T, Horn S, Brockmann M, Eilers U, Sch\u00fcttrumpf L, Popov N, Kenney AM, Schulte JH, Beijersbergen R, Christiansen H, et al. Stabilization of N-myc is a critical function of aurora A in human neuroblastoma. Cancer Cell. 2009;15:67\u201378. doi: 10.1016/j.ccr.2008.12.005.", "ArticleIdList": ["10.1016/j.ccr.2008.12.005", "19111882"]}, {"Citation": "Sun X, Niu S, Zhang Z, Wang A, Yang C, Guo Z, Hao Y, Li X, Wang X. Aurora kinase inhibitor VX-680 suppresses the proliferation and migration of HUVECs and angiogenesis. Mol Med Rep. 2019;19:3841\u20133847.", "ArticleIdList": ["30816538"]}, {"Citation": "Romain CV, Paul P, Lee S, Qiao J, Chung DH. Targeting Aurora kinase A inhibits hypoxia-mediated neuroblastoma cell tumorigenesis. Anticancer Res. 2014;34:2269\u20132274.", "ArticleIdList": ["PMC4165572", "24778030"]}, {"Citation": "Tang CJC, Lin CY, Tang TK. Dynamic localization and functional implications of Aurora-C kinase during male mouse meiosis. Dev Biol. 2006;290:398\u2013410. doi: 10.1016/j.ydbio.2005.11.036.", "ArticleIdList": ["10.1016/j.ydbio.2005.11.036", "16386730"]}, {"Citation": "Balboula AZ, Schindler K. Selective disruption of aurora C kinase reveals distinct functions from aurora B kinase during meiosis in mouse oocytes. PLoS Genet. 2014;10:e1004194. doi: 10.1371/journal.pgen.1004194.", "ArticleIdList": ["10.1371/journal.pgen.1004194", "PMC3937256", "24586209"]}, {"Citation": "Quartuccio SM, Schindler K. Functions of Aurora kinase C in meiosis and cancer. Front Cell Dev Biol. 2015;3:50. doi: 10.3389/fcell.2015.00050.", "ArticleIdList": ["10.3389/fcell.2015.00050", "PMC4542505", "26347867"]}, {"Citation": "Bavetsias V, Linardopoulos S. Aurora kinase inhibitors: Current status and outlook. Front Oncol. 2015;5:278. doi: 10.3389/fonc.2015.00278.", "ArticleIdList": ["10.3389/fonc.2015.00278", "PMC4685048", "26734566"]}, {"Citation": "Inamdar KV, O'Brien S, Sen S, Keating M, Nguyen MH, Wang X, Fernandez M, Thomazy V, Medeiros LJ, Bueso-Ramos CE. Aurora-A kinase nuclear expression in chronic lymphocytic leukemia. Mod Pathol. 2008;21:1428\u20131435. doi: 10.1038/modpathol.2008.173.", "ArticleIdList": ["10.1038/modpathol.2008.173", "18931650"]}, {"Citation": "Giet R, Petretti C, Prigent C. Aurora kinases, aneuploidy and cancer, a coincidence or a real link? Trends Cell Biol. 2005;15:241\u2013250. doi: 10.1016/j.tcb.2005.03.004.", "ArticleIdList": ["10.1016/j.tcb.2005.03.004", "15866028"]}, {"Citation": "Makarasen A, Sirithana W, Mogkhuntod S, Khunnawutmanotham N, Chimnoi N, Techasakul S. Cytotoxic and antimicrobial activities of aporphine alkaloids isolated from stephania venosa (Blume) spreng. Planta Med. 2011;77:1519\u20131524. doi: 10.1055/s-0030-1270743.", "ArticleIdList": ["10.1055/s-0030-1270743", "21305448"]}, {"Citation": "Thien DD, Thuy TT, Huy NQ, Van TH, Duong LTT, Tam NT. Cytotoxic alkaloids from stephania dielsiana. Chem Nat Compd. 2018;54:613\u2013616. doi: 10.1007/s10600-018-2426-8.", "ArticleIdList": ["10.1007/s10600-018-2426-8"]}, {"Citation": "Knockleby J, Pradines B, Gendrot M, Mosnier J, Nguyen TT, Trinh TT, Lee H, Le PM. Cytotoxic and anti-plasmodial activities of stephania dielsiana Y.C. Wu extracts and the isolated compounds. Molecules. 2020;25:3755. doi: 10.3390/molecules25163755.", "ArticleIdList": ["10.3390/molecules25163755", "PMC7465040", "32824689"]}, {"Citation": "Hoang TMN, Favier B, Valette A, Barette C, Nguyen CH, Lafanech\u00e8re L, Grierson DS, Dimitrov S, Molla A. Benzo[e] pyridoindoles, novel inhibitors of the aurora kinases. Cell Cycle. 2009;8:765\u2013772. doi: 10.4161/cc.8.5.7879.", "ArticleIdList": ["10.4161/cc.8.5.7879", "PMC3325905", "19221479"]}, {"Citation": "Hoang NTM, Phuong TT, Nguyen TTN, Tran YTH, Nguyen ATN, Nguyen TL, Bui KTV. In vitro characterization of derrone as an aurora kinase inhibitor. Biol Pharm Bull. 2016;39:935\u2013945. doi: 10.1248/bpb.b15-00835.", "ArticleIdList": ["10.1248/bpb.b15-00835", "26983907"]}, {"Citation": "McMillan KS, McCluskey AG, Sorensen A, Boyd M, Zagnoni M. Emulsion technologies for multicellular tumour spheroid radiation assays. Analyst. 2016;141:100\u2013110. doi: 10.1039/C5AN01382H.", "ArticleIdList": ["10.1039/C5AN01382H", "26456100"]}, {"Citation": "Lin YS, Su LJ, Yu CT, Wong FH, Yeh HH, Chen SL, Wu JC, Lin WJ, Shiue YL, Liu HS, et al. Gene expression profiles of the aurora family kinases. Gene Expr. 2006;13:15\u201326. doi: 10.3727/000000006783991962.", "ArticleIdList": ["10.3727/000000006783991962", "PMC6032448", "16572587"]}, {"Citation": "He J, Qi Z, Zhang X, Yang Y, Liu F, Zhao G, Wang Z. Aurora kinase B inhibitor barasertib (AZD1152) inhibits glucose metabolism in gastric cancer cells. Anticancer Drugs. 2019;30:19\u201326. doi: 10.1097/CAD.0000000000000684.", "ArticleIdList": ["10.1097/CAD.0000000000000684", "30540594"]}, {"Citation": "Romain C, Paul R, Kim KW, Lee S, Qiao J, Chung DH. Targeting Aurora kinase-A downregulates cell proliferation and angiogenesis in neuroblastoma. J Pediatr Surg. 2014;49:159\u2013165. doi: 10.1016/j.jpedsurg.2013.09.051.", "ArticleIdList": ["10.1016/j.jpedsurg.2013.09.051", "PMC4183462", "24439602"]}, {"Citation": "Roy JG, McElhaney JE, Verschoor CP. Reliable reference genes for the quantification of mRNA in human T-cells and PBMCs stimulated with live influenza virus. BMC Immunol. 2020;21:4. doi: 10.1186/s12865-020-0334-8.", "ArticleIdList": ["10.1186/s12865-020-0334-8", "PMC6995044", "32005148"]}, {"Citation": "Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25:402\u2013408. doi: 10.1006/meth.2001.1262.", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Bi H, Li H, Zhang C, Mao Y, Nie F, Xing Y, Sha W, Wang X, Irwin DM, Tan H. Stromal vascular fraction promotes migration of fibroblasts and angiogenesis through regulation of extracellular matrix in the skin wound healing process. Stem Cell Res Ther. 2019;10:302. doi: 10.1186/s13287-019-1415-6.", "ArticleIdList": ["10.1186/s13287-019-1415-6", "PMC6798485", "31623669"]}, {"Citation": "Li Y, Zhang ZF, Chen J, Huang D, Ding Y, Tan MH, Qian CN, Resau JH, Kim H, The BT. VX680/MK-0457, a potent and selective Aurora kinase inhibitor, targets both tumor and endothelial cells in clear cell renal cell carcinoma. Am J Transl Res. 2010;2:296\u2013308.", "ArticleIdList": ["PMC2892409", "20589168"]}, {"Citation": "P\u00e9rez-Fidalgo JA, Gambardella V, Pineda B, Burgues O, Pi\u00f1ero O, Cervantes A. Aurora kinases in ovarian cancer. ESMO Open. 2010;5:e000718. doi: 10.1136/esmoopen-2020-000718.", "ArticleIdList": ["10.1136/esmoopen-2020-000718", "PMC7580081", "33087400"]}, {"Citation": "Cervantes A, Elez E, Roda D, Ecsedy J, Macarulla T, Venkatakrishnan K, Rosell\u00f3 S, Andreu J, Jung J, Sanchis-Garcia JM, et al. Phase I pharmacokinetic/pharmacodynamic study of MLN8237, an investigational, oral, selective Aurora a kinase inhibitor, in patients with advanced solid tumors. Clin Cancer Res. 2012;18:4764\u20134774. doi: 10.1158/1078-0432.CCR-12-0571.", "ArticleIdList": ["10.1158/1078-0432.CCR-12-0571", "22753585"]}, {"Citation": "Falchook G, Coleman RL, Roszak A, Behbakht K, Matulonis U, Ray-Coquard I, Sawrycki P, Duska LR, Tew W, Ghamande S, et al. Alisertib in combination with weekly paclitaxel in patients with advanced breast cancer or recurrent ovarian cancer: A randomized clinical trial. JAMA Oncol. 2019;5:e183773. doi: 10.1001/jamaoncol.2018.3773.", "ArticleIdList": ["10.1001/jamaoncol.2018.3773", "PMC6439781", "30347019"]}, {"Citation": "Brito DA, Yang Z, Rieder CL. Microtubules do not promote mitotic slippage when the spindle assembly checkpoint cannot be satisfied. J Cell Biol. 2008;182:623\u2013629. doi: 10.1083/jcb.200805072.", "ArticleIdList": ["10.1083/jcb.200805072", "PMC2518701", "18710927"]}, {"Citation": "Willems E, Lombard A, Dedobbeleer M, Goffart N, Rogister B. The unexpected roles of aurora A kinase in gliobastoma recurrences. Target Oncol. 2017;12:11\u201318. doi: 10.1007/s11523-016-0457-2.", "ArticleIdList": ["10.1007/s11523-016-0457-2", "27573024"]}, {"Citation": "Wang JD, Zhang W, Zhang JW, Zhang L, Wang LX, Zhou HS, Long L, Lu G, Liu Q, Long ZJ. A novel aurora kinase inhibitor attenuates leukemic cell proliferation induced by mesenchymal stem cells. Mol Ther Oncolytics. 2020;18:491\u2013503. doi: 10.1016/j.omto.2020.08.001.", "ArticleIdList": ["10.1016/j.omto.2020.08.001", "PMC7479495", "32953983"]}, {"Citation": "Wu CC, Yu CTR, Chang GC, Lai JM, Hsu SL. Aurora-A promotes gefitinib resistance via a NF-\u03baB signaling pathway in p53 knockdown lung cancer cells. Biochem Bioph Res Commun. 2011;405:168\u2013172. doi: 10.1016/j.bbrc.2011.01.001.", "ArticleIdList": ["10.1016/j.bbrc.2011.01.001", "21216229"]}, {"Citation": "Chen J, Lu H, Zhou W, Yin H, Zhu L, Liu C, Zhang P, Hu H, Yang Y, Han H. AURKA upregulation plays a role in fibroblast-reduced gefitinib sensitivity in the NSCLC cell line HCC827. Oncol Rep. 2015;33:1860\u20131866. doi: 10.3892/or.2015.3764.", "ArticleIdList": ["10.3892/or.2015.3764", "PMC4440218", "25634113"]}, {"Citation": "Kasam RK, Ghandikota S, Soundararajan D, Reddy GB, Huang SK, Jegga AG, Madala SK. Inhibition of Aurora kinase B attenuates fibroblast activation and pulmonary fibrosis. EMBO Mol Med. 2020;12:e12131. doi: 10.15252/emmm.202012131.", "ArticleIdList": ["10.15252/emmm.202012131", "PMC7507328", "32761869"]}, {"Citation": "Kim HJ, Cho JH, Quan H, Kim JR. Down-regulation of Aurora B kinase induces cellular senescence in human fibro-blasts and endothelial cells through a p53-dependent pathway. FEBS Lett. 2011;585:3569\u20133576. doi: 10.1016/j.febslet.2011.10.022.", "ArticleIdList": ["10.1016/j.febslet.2011.10.022", "22024481"]}, {"Citation": "Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: Causes, consequences, challenges and opportunities. Cell Mol Life Sci. 2020;77:1745\u20131770. doi: 10.1007/s00018-019-03351-7.", "ArticleIdList": ["10.1007/s00018-019-03351-7", "PMC7190605", "31690961"]}, {"Citation": "Wang Z, Zhao Y, An Z, Li W. Molecular links between angiogenesis and neuroendocrine phenotypes in prostate cancer progression. Front Oncol. 2020;9:1491. doi: 10.3389/fonc.2019.01491.", "ArticleIdList": ["10.3389/fonc.2019.01491", "PMC6985539", "32039001"]}, {"Citation": "Villaume K, Blanc M, Gouysse G, Walter T, Couderc C, Nejjari M, Vercherat C, Cordier-Bussat M, Roche C, Scoazec JY. VEGF secretion by neuroendocrine yumor cells is inhibited by octreotide and by inhibitors of the PI3K/AKT/mTOR pathway. Neuroendocrinology. 2010;91:268\u2013278. doi: 10.1159/000289569.", "ArticleIdList": ["10.1159/000289569", "20389030"]}, {"Citation": "Ton AT, Singh K, Morin H, Ban F, Leblanc E, Lee J, Lallous N, Cherkasov A. Dual-inhibitors of N-Myc and AURKA as potential therapy for neuroendocrine prostate cancer. Int J Mol Sci. 2020;21:8277. doi: 10.3390/ijms21218277.", "ArticleIdList": ["10.3390/ijms21218277", "PMC7663809", "33167327"]}, {"Citation": "Sedl\u00e1\u0159 A, Tr\u00e1vn\u00ed\u010dkov\u00e1 M, Mat\u011bjka R, Pra\u017e\u00e1k \u0160, M\u00e9sz\u00e1ros Z, Bojarov\u00e1 P, Ba\u010d\u00e1kov\u00e1 L, K\u0159en V, Sl\u00e1mov\u00e1 K. Growth factors VEGF-A165 and FGF-2 as multifunctional biomolecules governing cell adhesion and proliferation. Int J Mol Sci. 2021;22:1843. doi: 10.3390/ijms22041843.", "ArticleIdList": ["10.3390/ijms22041843", "PMC7917819", "33673317"]}, {"Citation": "Cao R, Eriksson A, Kubo H, Alitalo K, Cao Y, Thyberg J. Comparative evaluation of FGF-2-, VEGF-A-, and VEGF-C-induced angiogenesis, lymphangiogenesis, vascular fenestrations, and permeability. Circ Res. 2004;94:664\u2013670. doi: 10.1161/01.RES.0000118600.91698.BB.", "ArticleIdList": ["10.1161/01.RES.0000118600.91698.BB", "14739162"]}, {"Citation": "Grugan KD, Miller CG, Yao Y, Michaylira CZ, Ohashi S, Klein-Szanto AJ, Diehl JA, Herlyn M, Han M, Nakagawa H, Rustgi AK. Fibroblast-secreted hepatocyte growth factor plays a functional role in esophageal squamous cell carcinoma invasion. Proc Natl Acad Sci USA. 2010;107:11026\u201311031. doi: 10.1073/pnas.0914295107.", "ArticleIdList": ["10.1073/pnas.0914295107", "PMC2890722", "20534479"]}, {"Citation": "Sahni A, Francis CW. Stimulation of endothelial cell proliferation by FGF-2 in the presence of fibrinogen requires alphavbeta3. Blood. 2004;104:3635\u20133641. doi: 10.1182/blood-2004-04-1358.", "ArticleIdList": ["10.1182/blood-2004-04-1358", "15297314"]}, {"Citation": "Huy NQ, Trang NTM. Evaluation the anti-tumor activity of SM2 fraction extracted from Stephania dielsiana Y.C.Wu on Swiss mice bearing S180 sarcoma tumor. Vietnam Pharm J. 2015;55:42\u201345. In Vietnamese."}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "4", "Day": "15"}, {"Year": "2022", "Month": "8", "Day": "24"}, {"Year": "2022", "Month": "9", "Day": "14", "Hour": "6", "Minute": "32"}, {"Year": "2022", "Month": "9", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "16", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "13"}], "PublicationStatus": "ppublish", "ArticleIdList": ["36102296", "PMC9558763", "10.3892/ijmm.2022.5189", "133"]}}], "PubmedBookArticle": []}